YONDJEU MEDICAL: what changed
YONDJEU MEDICAL
Largest movements
- Cash +€3,072
up €3,072 (+37.7%), from €8,156 to €11,228
mainly Net result for the year (+€2,437) and Tax, wage and social debts (+€1,686)
- Deferred charges and accrued income +€1,558
up €1,558 (+101%), from €1,549 to €3,108
- Profit (loss) carried forward +€2,437
up €2,437 (+127%), from €1,924 to €4,361
- Tax, wage and social debts +€1,686
new in 2025: €1,686
- Other debts +€1,539
up €1,539 (+30.0%), from €5,132 to €6,672
- Trade debts -€1,032
down €1,032 (-89.8%), from €1,149 to €117
- Gross operating margin +€1,183
up €1,183 (+58.9%), from €2,011 to €3,194
- Taxes +€652
new in 2025: €652
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,705 | €14,335 | +€4,630 | +47.7% |
| Current assets | 29/58 | €9,705 | €14,335 | +€4,630 | +47.7% |
| Cash at bank and in hand | 54/58 | €8,156 | €11,228 | +€3,072 | +37.7% |
| Deferred charges and accrued income | 490/1 | €1,549 | €3,108 | +€1,558 | +101% |
| Total equity and liabilities | 10/49 | €9,705 | €14,335 | +€4,630 | +47.7% |
| Equity | 10/15 | €3,424 | €5,861 | +€2,437 | +71.2% |
| Contributions | 10/11 | €1,500 | €1,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,924 | €4,361 | +€2,437 | +127% |
| Amounts payable | 17/49 | €6,282 | €8,475 | +€2,193 | +34.9% |
| Amounts payable within one year | 42/48 | €6,282 | €8,475 | +€2,193 | +34.9% |
| Trade debts | 44 | €1,149 | €117 | -€1,032 | -89.8% |
| Suppliers | 440/4 | €1,149 | €117 | -€1,032 | -89.8% |
| Taxes, remuneration and social security | 45 | - | €1,686 | +€1,686 | |
| Taxes | 450/3 | - | €1,686 | +€1,686 | |
| Other amounts payable | 47/48 | €5,132 | €6,672 | +€1,539 | +30.0% |
| Gross operating margin | 9900 | €2,011 | €3,194 | +€1,183 | +58.9% |
| Operating profit (loss) | 9901 | €2,011 | €3,194 | +€1,183 | +58.9% |
| Financial charges | 65/66B | €87 | €105 | +€18 | +20.7% |
| Recurring financial charges | 65 | €87 | €105 | +€18 | +20.7% |
| Profit (loss) for the period before taxes | 9903 | €1,924 | €3,089 | +€1,165 | +60.6% |
| Income taxes | 67/77 | - | €652 | +€652 | |
| Profit (loss) for the period | 9904 | €1,924 | €2,437 | +€513 | +26.7% |
| Profit (loss) for the period to be appropriated | 9905 | €1,924 | €2,437 | +€513 | +26.7% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.